121 – 130 of 160
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Global, regional, and national levels of maternal mortality, 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015
(
- Contribution to journal › Article
-
Mark
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015
(
- Contribution to journal › Article
-
Mark
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015
(
- Contribution to journal › Article
-
Mark
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015
(
- Contribution to journal › Article
-
Mark
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015 : a systematic analysis for the Global Burden of Disease Study 2015
(
- Contribution to journal › Article
-
Mark
Measuring the health-related Sustainable Development Goals in 188 countries : a baseline analysis from the Global Burden of Disease Study 2015
(
- Contribution to journal › Article
-
Mark
Association of knee pain and different definitions of knee osteoarthritis with health-related quality of life : A population-based cohort study in southern Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
The prevalence of adulthood overweight and obesity in Tehran: findings from Urban HEART-2 study.
(
- Contribution to journal › Article
-
Mark
Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
(
- Contribution to journal › Article
-
Mark
Cost effectiveness analysis of Avonex and CinnoVex in Relapsing Remitting MS
(
- Contribution to journal › Article